Moreover, interaction of MAPs and actin in the organization of the cytoskeletal network is well-documented [28]–[35] and emerging evidence suggests that these interactions may be central to the processes involved in the initiation and development of early AD pathology [20], [22], [36], [37]. This evidence concerns the gene C3orf62 and Alzheimer disease.